HOME >> MEDICINE >> NEWS
Four-year data show risk of relapse is halved in Risperdal patients compared to haloperidol

21 September 2003 Prague - Treatment with RISPERDAL(risperidone), a newer- generation, 'atypical' antipsychotic medication, significantly reduces the risk of relapse in individuals experiencing their first episode of schizophrenia, even when using the lowest possible dose. Findings from the "FutuRis" study, the longest-term study in this population ever conducted, were presented today for the first time at the 16th Congress of the European College of Neuropsychopharmacology (ECNP)1,2,3.

"The results from this study are very encouraging, because schizophrenia is a life-long illness. This new research shows that if we can intervene effectively right at the start of the illness, upon the first psychotic episode, we may be able to prevent some of the consequences of this very debilitating disease,' said Professor Robin Emsley, MD, core investigator and head of the Department of Psychiatry at the University of Stellenbosch, South Africa. "We know that every time a person with schizophrenia relapses, it makes recovery slower and increases the frequency of future hospitalisation. The illness can also become more difficult to treat and -- in some cases -- resistant to treatment altogether. Therefore, it is essential that we minimise the number of relapses as much as possible early in the course of the disease."

The randomised, double-blind study followed 535 people with schizophrenia who took between 1-8 mg of risperidone or haloperidol per day for one to four years. It found that of the approximately three-quarters of patients who went into remission, 42 percent of those taking risperidone later relapsed, versus more than half (55 percent) for the older, conventional drug haloperidol. Haloperidol was chosen as the comparator because it is the most widely prescribed of the conventional antipsychotics. The study also showed that risperidone patients were relapse-free for more than twice as long as those receiving haloperidol (an average of more than 15
'"/>

Contact: Roseann Ward
roseann.ward@resolutecommunications.com
44-20-7357-8187
Resolute Communications
22-Sep-2003


Page: 1 2

Related medicine news :

1. Study finds factors linked to substance use disorder relapse among health care professionals
2. UW research shows risk factors for relapse among health care professionals who abuse drugs
3. Alcohol relapse adversely affects 10-year liver transplant survival
4. More than half of relapsed CLL patients respond to two biologics with chemotherapy
5. Study finds Velcade major improvement over standard therapy for relapsed multiple myeloma patients
6. Study uncovers how stress and hormones lead to smoking relapse
7. New guidelines for drug studies for relapsed prostate cancer patients
8. Molecular test proves to be effective in measuring remission and relapse after cancer treatment
9. 18F-FDG PET better predictor of post-therapy Hodgkins relapse than CT
10. Rutgers scientists pinpoint brain cells involved in drug addiction relapse
11. Meningococcal C vaccine could increase relapse for children with kidney disease

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... 2020 , ... “Frozen.” It’s not simply the title of a popular family ... reasons – resulting in stiffness, persistent pain and loss of range of motion. So, ... the upper limbs and joints and founder and chief medical officer of the Florida-based ...
(Date:7/18/2020)... ... July 17, 2020 , ... Nader Sanai, M.D., director ... have come together for the second annual Glioblastoma Awareness Day (#GBMDay) on July 22, ... to increasing public awareness of glioblastoma , the most common and aggressive form ...
(Date:7/18/2020)... ... July 18, 2020 , ... The Dentists, LLC is an established general dental ... 35 years. NJ Top Dentists, Dr. Georgette Bennardo-Meggelin and Dr. Aliza E. Staiman lead ... dentistry. , “We are committed to making our patients’ treatment comfortable and enjoyable. We ...
(Date:7/10/2020)... ... July 10, 2020 , ... Circularity announced ... Circularity Healthcare’s mission to provide real and affordable healthcare solutions , will ... future pandemics by ending the commercial trade in wild animals, expanding wild habitats, ...
(Date:7/10/2020)... ... July 10, 2020 , ... Health ... its newest offering, Liposuction 360 . The group, with offices located throughout ... catalog of plastic surgeries and cosmetic procedures is an exciting new addition to ...
Breaking Medicine News(10 mins):
(Date:8/3/2020)... ... 03, 2020 , ... What is the purpose of sleep? Most of us would answer, “to ... Other than when we feel sick or tired from a long day at work, or ... accusing our poor sleeping habits or our own daily choices of how we spend our ...
(Date:7/31/2020)... ... 31, 2020 , ... A June 29 article on Healthline reports ... caused by tiny worms that inhabited the mouths of those afflicted. The article goes ... creatures that are commonly found in water supplies. Marina Del Rey-based dental center Elegant ...
(Date:7/22/2020)... ... July 22, 2020 , ... CMI/Compas, a leading media strategy, ... of WPP (NYSE:WPP), has continued its investment in consumer media strategy with the ... further into healthcare consumer media, Warren will be responsible for operationalizing full-service consumer ...
Breaking Medicine Technology:
Cached News: